Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The risk of hypoglycemia is low with GLP-1-mimetic drugs (eg, exenatide [Byetta], liraglutide [Victoza]) because their effects are dependent on high levels of glucose in the bloodstream
Tokyo Chemical Industry Co., Ltd
The research team stated, "We have provided direct genetic evidence that variants in the drug's target gene create differences in treatment response." They added, "Using genetic information, we can predict which drug will work best for each patient and what side effects to expect before starting treatment." In a commentary published alongside the study in Nature, Ruth J.F
Monitor your progress systematically Track more than just weight
